Evaluation of plasma stability and pharmacokinetics of parthenolide in rats with LC-MS/MS analysis

Xuan QIN,Ang CHEN,Jian LU,Yuan-jin ZHANG,Ming-yao LIU,Xin WANG

DOI: https://doi.org/10.16438/j.0513-4870.2016-1006

2017-01-01

Abstract:Parthenolide is a sesquiterpene lactone derived from the plant feverfew (Tanacetum parthenium)that possesses multiple anti-inflammatory and anti-cancer properties.A specific,sensitive,accurate and precise LC-MS/MS method was developed and validated in the quantitative analysis of parthenolide in rat plasma.A liquid-liquid extraction method was used to separate the analyte and the internal standard (IS,costunolide) from plasma.A water-methanol mobile phase system was utilized in the gradient chromatographic separation.The calibration curve with good linearity (r2＞ 0.99) was established between 2 and 128 ng ·mL-1 with accuracy and precision within acceptable limits at different QC levels.High extraction recovery was achieved for both parthenolide (89.55％-95.79％) and IS (96.87％).Based on this LC-MS/MS method,the plasma stability and pharmacokinetics of parthenolide were assessed in rats.Parthenolide was proved to be very unstable in rat plasma,and was distributed and eliminated quickly in vivo,with a half-life less than 90 min.A high dose of parthenolide (80 mg·kg 1) resulted in a very low initial concentration (138.86 ±21.07 ng·mL 1).The systemic exposure of parthenolide (area under the curve) increased disproportionally from 40 mg ·kg 1 dose group to 80 mg·kg-1 dose group.The present study may provide helpful information for the development ofparthenolide as a drug candidate.